Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Busulfan, Cyclophosphamide, Antithymocyte Globulin
(D00287)		[2] Busulfan,
Cyclophosphamide		[3] Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 19, 20 💬
2Busulfan, Cyclophosphamide, ATG
(D00287)		[2] Busulfan,
Cyclophosphamide		[3] Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 19 💬
3Busulfan, Cyclophosphamide, ATG, GCSF
(D00287)		[2] Busulfan,
Cyclophosphamide		[3] Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 65, 284 💬
4Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)
(D00287)		[3] Busulfan,
Cyclophosphamide,
Fludarabine		[5] Busulfan ,
Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 326 💬
5Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
(D00287)		[4] Busulfan,
Cyclophosphamide,
Cyclosporine,
Fludarabine		[6] Cyclosporine ,
Busulfan ,
Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[6] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬 		[37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[2] 60, 285 💬
6CABA-201 following preconditioning with fludarabine and cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 50 💬
7Campath, Fludarabine, Cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[2] 65, 284 💬
8CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE
(D00287)		[3] Carfilzomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide (D00287),
Dexamethasone ,
Dexamethasone sodium phosphate ,
Cyclophosphamide ,
Dexamethasone phosphate ,
Carfilzomib 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 16 💬
9Chemotherapy: cyclophosphamide (CYC)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 13 💬
10Cyclophosphamide
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[50] 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
11Cyclophosphamide (CTX)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 28, 222 💬
12Cyclophosphamide (CY)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
13Cyclophosphamide (CY) (Plan 1)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[3] 60, 65, 285 💬
14Cyclophosphamide (CY) (Plan 2)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[3] 60, 65, 285 💬
15Cyclophosphamide (CYC)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 49, 221 💬
16Cyclophosphamide (Cytoxan)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 65 💬
17Cyclophosphamide (drug)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 13 💬
18Cyclophosphamide + pred
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 283 💬
19Cyclophosphamide 100 mg/Kg
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 19, 222 💬
20Cyclophosphamide 100mg
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
21Cyclophosphamide 1200 mg/Kg
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 19, 222 💬
22Cyclophosphamide 150mg
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
23Cyclophosphamide 50mg
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
24Cyclophosphamide 50Mg Oral Tablet
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 162 💬
25Cyclophosphamide added to standard immunosuppressive therapy with herombopag
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
26Cyclophosphamide and ATG
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 13 💬
27Cyclophosphamide and fludarabine
(D00287)		[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[4] 11, 13, 14, 16 💬
28Cyclophosphamide and steroids
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 222, 223 💬
29Cyclophosphamide Dose Level 1
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 65, 284 💬
30Cyclophosphamide Dose Level 2
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 65, 284 💬
31Cyclophosphamide Dose Level 3
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 65, 284 💬
32Cyclophosphamide Dose Level 4
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[2] 65, 284 💬
33Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids
(D00287)		[3] Azathioprine,
Cyclophosphamide,
Methotrexate		[6] Methotrexate ,
Azathioprine ,
Cyclophosphamide (D00287),
Methotrexate sodium ,
Azathioprine sodium ,
Cyclophosphamide 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 44 💬
34Cyclophosphamide Injection 1g
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[3] 50, 51, 52 💬
35Cyclophosphamide LD
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 49 💬
36CYCLOPHOSPHAMIDE MONOHYDRATE
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[4] 13, 60, 96, 256 💬
37Cyclophosphamide post transplant
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 65 💬
38Cyclophosphamide(CTX)
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 224 💬
39Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(D00287)		[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		[7] Azathioprine ,
Cyclophosphamide (D00287),
Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate ,
Azathioprine sodium ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
40Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
(D00287)		[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide (D00287),
Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
41Cyclophosphamide, Fludarabine
(D00287)		[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 285 💬
42Cyclophosphamide, fludarabine , thymoglobulin
(D00287)		[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 60 💬
43Cyclophosphamide, Fludarabine, Rabbit ATG
(D00287)		[3] Cyclophosphamide,
Fludarabine,
Rabbit		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 60 💬
44Cyclophosphamide, Fludarabine, Thymoglobulin
(D00287)		[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 60 💬
45Cyclophosphamide,Campath IH and TBI
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
46Cyclophosphamide,cyclosporine A
(D00287)		[2] Cyclophosphamide,
Cyclosporine		[3] Cyclosporine ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 60 💬
47Cyclophosphamide-prednisone-azathioprine
(D00287)		[3] Azathioprine,
Cyclophosphamide,
Prednisone		[5] Azathioprine ,
Cyclophosphamide (D00287),
Prednisone ,
Azathioprine sodium ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
48Cyclophosphamide/ATG
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 13 💬
49Cyclophosphamide/azathioprine
(D00287)		[2] Azathioprine,
Cyclophosphamide		[4] Azathioprine ,
Cyclophosphamide (D00287),
Azathioprine sodium ,
Cyclophosphamide 💬 		--[1] 44 💬
50Cyclophosphamide/Glatiramer acetate
(D00287)		[3] Acetate,
Cyclophosphamide,
Glatiramer		[3] Cyclophosphamide (D00287),
Glatiramer acetate ,
Cyclophosphamide 💬 		[20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
51Cyclophosphamide/Rituximab
(D00287)		[2] Cyclophosphamide,
Rituximab		[3] Cyclophosphamide (D00287),
Rituximab ,
Cyclophosphamide 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
52Dexamethasone Cyclophosphamide Pulse therapy
(D00287)		[2] Cyclophosphamide,
Dexamethasone		[5] Cyclophosphamide (D00287),
Dexamethasone ,
Dexamethasone sodium phosphate ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
53Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase
(D00287)		[3] Cyclophosphamide,
Doxorubicin,
Methotrexate		[6] Methotrexate ,
Cyclophosphamide (D00287),
Doxorubicin hydrochloride ,
Methotrexate sodium ,
Doxorubicin ,
Cyclophosphamide 💬 		[2] DHFR,
DHFR2 💬 		[3] Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬[1] 65 💬
54Fludarabine, Cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Fludarabine		[4] Cyclophosphamide (D00287),
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		[1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[2] 60, 222 💬
55Glucocorticoid combined with cyclophosphamide induction + maintenance
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 222 💬
56Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
57High-dose Cyclophosphamide
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 96 💬
58ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following cyclophosphamide-only lymphodepletion
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 49 💬
59IV Cyclophosphamide
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 51 💬
60Lenalidomide, Dexamethasone and Cyclophosphamide
(D00287)		[3] Cyclophosphamide,
Dexamethasone,
Lenalidomide		[6] Cyclophosphamide (D00287),
Dexamethasone ,
Dexamethasone sodium phosphate ,
Lenalidomide ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28 💬
61Oral prednisolone and cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Prednisolone		[3] Cyclophosphamide (D00287),
Prednisolone ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
62Prednisolone plus Cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Prednisolone		[3] Cyclophosphamide (D00287),
Prednisolone ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
63Prednisone and cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
64Prednisone plus cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
65Prednisone, cyclophosphamide
(D00287)		[2] Cyclophosphamide,
Prednisone		[3] Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 40 💬
66Prednisone,methylprednisone and cyclophosphamide
(D00287)		[3] Cyclophosphamide,
Methylprednisone,
Prednisone		[3] Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
67Reduced dose of cyclophosphamide combined with standard immunosuppressive therapy
(D00287)		[1] Cyclophosphamide[2] Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--[1] 60 💬
68Rituxan, Cyclophosphamide, Vincristine, Prednisone
(D00287)		[3] Cyclophosphamide,
Prednisone,
Vincristine		[5] Cyclophosphamide (D00287),
Prednisone ,
Vincristine sulfate ,
Cyclophosphamide ,
Vincristine 💬 		[10] NR3C1,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[13] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 63 💬
69Rituximab and Cyclophosphamide IV
(D00287)		[2] Cyclophosphamide,
Rituximab		[3] Cyclophosphamide (D00287),
Rituximab ,
Cyclophosphamide 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 35 💬
70Rituximab, Cyclophosphamide, and Corticosteroids
(D00287)		[2] Cyclophosphamide,
Rituximab		[3] Cyclophosphamide (D00287),
Rituximab ,
Cyclophosphamide 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 222 💬
71SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
(D00287)		[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide (D00287),
Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
72Thalidomide, cyclophosphamide and prednisone
(D00287)		[3] Cyclophosphamide,
Prednisone,
Thalidomide		[4] Cyclophosphamide (D00287),
Prednisone ,
Thalidomide ,
Cyclophosphamide 💬 		[2] NR3C1,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 331 💬